Endexx's CBD Unlimited Division, which launched in late April
2015, is a proprietary e-commerce site that offers
phyto-cannabinoids products, which are derived from the whole hemp
plant. The Company secured a high quality supply chain of imported
industrial hemp based Cannabidiol (CBD) extracts and nutritional
products to help develop Phyto-Nutrient© rich solutions for health
needs.
Mr. Riley's primary responsibilities are to establish a sales
and marketing infrastructure and manage sales growth nationally. In
addition, he will be managing customer relationships across
multiple channels of trade and collaborating with retailers to
design, present and implement Endexx's go to market initiatives.
Given his background, Mr. Riley will spearhead the development of
sales strategies, identification of new customers, preparation and
performance of new item presentations to retailers and perform
profitability of deals and ROI analysis which includes post
promotional analysis, competitive reporting, forecast business
volumes, and the negotiation of master agreements.
Mr. Riley has over 20 years of experience in the food, beverage
and nutraceutical industry. He has worked with his family's
multi-generational food brokerage company, the Joseph W. Riley
Company, which generated annual sales of $500 million. After the
sale of the brokerage company, he managed a pet products company,
Glamour Kitty Products, growing the business from a single product
to multiple line extensions, and from regional to national markets,
making it the sixth largest company in its category. In recent
years, Mr. Riley has been instrumental in helping consumer products
companies launch and succeed in the marketplace through his
relationships with retailers and his strong network of resources
that has helped propel companies and their brands.
Brendon Riley's states that, "People are looking for healthy
alternatives, non- addictive treatments that are safe and legal.
This product reaches a large demographic, including athletes, the
elderly, prescription dependent people and families. Society is
ready for a product like this. Progressive retailers, seeking
innovative, unique and different products lines, will need to get
behind us to support this product getting to the market. After
experiencing and seeing how CBD has benefited my family and
friends, I am convinced. To be blunt, people are tired of using
heavy drugs in their fight for better health, and that's where I
believe Endexx and CBD Unlimited are forging a path in the educated
consumer market for natural products."
Todd Davis, CEO of Endexx, stated, "Endexx has now established a
successful early stage footprint in the retail space. We have
secured our key product and sourcing partners and have positioned
the company to scale up to meet the demand of commercial level
retail customers. Brendon has already helped develop and drive
sales of product lines in all categories Endexx is pursing,
including health and wellness, sports nutrition, nutraceuticals,
and pet care markets. He leads a network of well-established food
and beverage brokers that sell in all major retailers in the US,
and will provide critical expertise in leading our commercial sales
strategy while going to market with our CBD line of products.
Distribution is the key to Endexx's success in this exciting new
market, and we believe Brendon provides the necessary skills and
network to achieve this objective."
After launching CBD Unlimited, revenues grew at roughly 20% per
month through November. In December 2015, the Company initiated a
campaign to bring its products into small retail health food,
vitamin and wellness stores. By February 2016, Endexx established
customer retail stores in approximately 10 states, with more than
50% of the stores acting on repeat orders within the first 30 days.
Since launching the program, Endexx has received high product
demand and sales have increased 50-100% per month for both retail
and wholesale accounts.
About Endexx
Endexx provides innovative medical marijuana management and
technology solutions. Endexx, with its collaborative partners and
consultants, develops and distributes two consumable product lines
derived from industrial hemp, which is organic and naturally rich
in phytocannabinoids. The company has two technology products and
services that launched in 2014 -- the M3hub and the Autospense™.
Both products provide essential solutions to promote regulatory
compliance and full accountability through "seed to sale" inventory
management and tracking. Based on principles developed by the
pharmacological industry, the m3hub platform is the first
standardized software solution for tracking pharmaceutical grade
marijuana that maintains compliance with federal, state and local
regulations. It is intended to provide a smooth transition to an
eventual federal mandates. The Autospense™ is a high-tech marijuana
inventory control and dispensing device that provides
up-to-the-minute accounting details and ensures both product and
patient security. By automating the dispensing process, Autospense™
increases productivity and reduces costs for marijuana retailer,
while enhancing their service quality by reducing transaction time
for customers. Websites include: www.cbdunlimited.com, www.cbdhealthsolutions.com, www.endexx.com, www.m3hub.com.
Safe Harbor Notice
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995, such as statements relating to financial results and plans
for future development activities, and are thus prospective.
Forward-looking statements include all statements that are not
statements of historical fact regarding intent, belief or current
expectations of the Company, its directors or its officers.
Investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, many of which are beyond the Company's ability to
control. Actual results may differ materially from those projected
in the forward-looking statements. Among the factors that could
cause actual results to differ materially from those indicated in
the forward-looking statements are risks and uncertainties
associated with the Company's business and finances in general,
including the ability to continue and manage its growth,
competition, global economic conditions and other factors discussed
in detail in the Company's periodic filings with the Security and
Exchange Commission. The Company undertakes no obligation to update
any forward-looking statements.